Canopy Growth (CGC) News
Latest news and analysis
Canopy Growth Sparks European Cannabis Rally Amid Sector Revival
CGC's European expansion strategy triggers broader cannabis stock momentum as investors reassess international opportunities beyond struggling North American markets.
Trump Orders Federal Cannabis Rescheduling: CGC Faces New Market Reality
Presidential directive on medical marijuana rescheduling creates regulatory shift with direct implications for major cannabis operators and institutional investment flows.
Canopy Growth Leads European Cannabis Rally Amid Sector Rotation
CGC stock drives broader cannabis equity momentum in European markets as institutional investors reassess sector fundamentals following regulatory shifts.
CGC Pivots Strategy as US Cannabis Reform Timeline Extends
Canopy Growth adjusts operational focus while federal legalization delays create strategic uncertainty for cross-border expansion plans.
CGC Stock Tracks Broader Market as Cannabis Correlation Tightens
Canopy Growth's price action mirrors Nasdaq moves, highlighting sector's shift toward traditional equity market dynamics amid regulatory uncertainty.
Canopy Growth Stock Surges on German Cannabis Market Re-Entry Strategy
CGC shares climb as cannabis giant pivots back to German operations, targeting Europe's largest medical cannabis market amid regulatory shifts.
CGC Stock Down 99%: Analyzing Canopy Growth's Turnaround Potential
Canopy Growth's massive decline raises questions about whether the cannabis giant can recover from operational missteps and market headwinds.
Canopy Growth's 99% Decline Raises Fundamental Value Questions
CGC trades near historic lows after massive value destruction, but rock-bottom prices don't guarantee recovery potential for cannabis investors.
Canopy Growth Stock Plunges Below $1: Second Reverse Split Looms
CGC shares fall under $1 threshold again, triggering potential Nasdaq delisting concerns and raising questions about another reverse split to maintain compliance.
Canopy Growth Eyes European Expansion as Cannabis Markets Evolve
CGC advances European strategy while navigating regulatory shifts and market consolidation pressures in global cannabis industry.
Canopy Growth Surges on MTL Cannabis Acquisition Strategy
CGC shares jump as cannabis giant expands Quebec footprint through strategic MTL Cannabis deal, signaling renewed M&A focus amid market consolidation.
Canopy Growth Analyst Sets $40 Price Target on Cannabis Legalization Bet
Wall Street analyst projects 300% upside for CGC shares as federal cannabis reform momentum builds, citing regulatory tailwinds and market positioning.
Canopy Growth Bulls Eye 300% Upside Despite Sector Headwinds
Single analyst projects 4x returns for CGC stock as cannabis sector faces persistent bearish sentiment and operational challenges.
Canopy Growth Rallies as Germany Opens Medical Cannabis Market
CGC shares jump on Germany's medical cannabis liberalization, positioning the company for European expansion as regulatory barriers fall across key markets.
Canopy Growth Targets Nasdaq Composite Inclusion as Cannabis Reforms Gain Moment
CGC positioning for major index inclusion as regulatory shifts create new opportunities for institutional investment in cannabis sector.